在瘤免疫和治疗中使用素
Michael R Pitter1,2, Weiping Zou1,2,3,4,5,6
1Department of Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA.
The Journal of clinical investigation
|October 15, 2025
概括
基氨酸减小酶 (PADs) 通过素化修改蛋白质,影响瘤微环境中的免疫细胞. 针对这个过程可能会提供新的癌症免疫治疗策略.
科学领域:
- 生物化学 生化学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 氨基氨酸减小酶 (PADs) 催化蛋白质素化,这是一个翻译后的修饰.
- 这种修饰改变了蛋白质的电荷,影响了折叠,稳定性,形状和功能.
- PAD2和PAD4是可以进入细胞核以化蛋白质的关键酶.
研究的目的:
- 审查瘤微环境中的免疫细胞中PAD2-和PAD4-介导的素化作用.
- 讨论素化如何影响免疫细胞功能和抗瘤免疫力.
- 探索向癌症免疫疗法中向素化治疗的治疗潜力.
主要方法:
- 文献审查侧重于PAD2和PAD4功能.
- 对研究免疫细胞中蛋白质素化研究的研究分析.
- 探索现有和潜在的癌症免疫疗法策略,以向素化.
主要成果:
- 通过PAD2和PAD4进行的细胞化显著影响瘤微环境中的免疫细胞子集.
- 蛋白质素化调节免疫细胞功能和整体瘤免疫力的关键方面.
- 有证据表明,向素化通路可以调节抗瘤免疫反应.
结论:
- 通过PAD2和PAD4介导的氨酸在调节瘤微环境中的免疫反应中起着至关重要的作用.
- 向蛋白质素化为开发新型癌症免疫疗法提供了一个有希望的途径.
- 进一步研究PAD介导的氨基酸可以解锁癌症治疗的新疗法策略.
更多相关视频
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.7K
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
12.2K
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Cytotoxic T Cells-mediated Immune Response
6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
